Russell Barber
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 9
- Genetics 5
- Genetic Associations and Epidemiology 5
- Journals
- JAMA (5 papers)Nature (4 papers)The Lancet (1 paper)EClinicalMedicine (1 paper)Human Genetics and Genomics Advances (1 paper)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Russell Barber
15 papers receiving 2.0k citations
Russell Barber's Hit Papers
Peers
Comparison fields: 5 of 72
- Infectious Diseases 764
- Applied Microbiology and Biotechnology 29
- Genetics 277
- Neurology 63
- Statistics and Probability 34
Countries citing papers authored by Russell Barber
This map shows the geographic impact of Russell Barber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Russell Barber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Russell Barber more than expected).
Fields of papers citing papers by Russell Barber
This network shows the impact of papers produced by Russell Barber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Russell Barber. The network helps show where Russell Barber may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 3 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 4 | 2021 | 166 | |
| 5 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 6 | 2022 | 105 | |
| 7 | 2022 | 100 | |
| 8 | 2021 | 72 | |
| 9 | 2023 | 60 | |
| 10 | 2023 | 46 | |
| 11 | 2023 | 34 | |
| 12 | 2023 | 25 | |
| 13 | 2024 | 8 | |
| 14 | 2025 | 5 | |
| 15 | 2025 | 2 | |
| 16 | 2021 | 0 |
About Russell Barber
Russell Barber is a scholar working on Infectious Diseases, Genetics, Nutrition and Dietetics, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 16 papers that have together received 2.0k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (9 papers), Genetic Associations and Epidemiology (5 papers) and Vitamin C and Antioxidants Research (1 paper). The work is most often cited by research in Infectious Diseases (764 citations), Applied Microbiology and Biotechnology (29 citations), Genetics (277 citations), Neurology (63 citations) and Statistics and Probability (34 citations). Russell Barber has collaborated with scholars based in United Kingdom, Australia and United States. Their work appears in journals such as JAMA, Nature, The Lancet, EClinicalMedicine and Human Genetics and Genomics Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.